Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Localized scleroderma and systemic sclerosis: is there a connection?

Rajnish A Gupta1, David Fiorentino

  • 1Department of Dermatology, Stanford University Medical Center, Stanford, CA 94305, USA.

Best Practice & Research. Clinical Rheumatology
|December 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Aided Lung Ultrasound Detection of Interstitial Lung Disease in Systemic Sclerosis and Inflammatory Myopathy.

Arthritis care & research·2026
Same author

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

The New England journal of medicine·2026
Same author

Autoantibodies as biomarkers of cancer risk in dermatomyositis.

JID innovations : skin science from molecules to population health·2026
Same author

RNA origin of sex-biased immunity.

Molecular therapy. Nucleic acids·2026
Same author

Identification of Adult Patients With Dermatomyositis Using Real-World Data Sources.

Arthritis care & research·2025
Same author

Risk of head and neck cancer in dermatomyositis: Findings from a retrospective US-based cohort study.

Journal of the American Academy of Dermatology·2025
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Localized scleroderma, a skin condition, may progress to systemic sclerosis, affecting internal organs. This study explores the potential link between these two fibrotic diseases, particularly in juvenile cases.

Area of Science:

  • Dermatology
  • Rheumatology
  • Fibrotic Diseases

Background:

  • Excessive skin fibrosis characterizes both localized scleroderma and systemic sclerosis.
  • Localized scleroderma is typically considered skin-limited, while systemic sclerosis can involve internal organs.
  • Emerging evidence indicates a subset of juvenile localized scleroderma patients may develop systemic disease progression.

Purpose of the Study:

  • To investigate the potential connection between localized scleroderma and systemic sclerosis.
  • To understand if juvenile localized scleroderma can evolve into systemic sclerosis.
  • To clarify the relationship between these two fibrotic skin conditions.

Main Methods:

  • Review of recent clinical data and case studies.
  • Comparative analysis of disease progression in juvenile localized scleroderma patients.

Related Experiment Videos

  • Examination of potential shared etiological factors and clinical trajectories.

    • Main Results:

    • Data suggest a subset of juvenile localized scleroderma patients exhibit progression towards systemic involvement.
    • The transition from localized to systemic disease highlights a potential continuum between the two conditions.
    • Further research is needed to fully elucidate the mechanisms driving this progression.

    Conclusions:

    • A subset of juvenile localized scleroderma may represent an early stage of systemic sclerosis.
    • Understanding this connection is crucial for early diagnosis and management of systemic involvement.
    • Further investigation into the pathogenesis and predictive markers is warranted.